CA2086101A1 - Produit immunosuppressif - Google Patents

Produit immunosuppressif

Info

Publication number
CA2086101A1
CA2086101A1 CA002086101A CA2086101A CA2086101A1 CA 2086101 A1 CA2086101 A1 CA 2086101A1 CA 002086101 A CA002086101 A CA 002086101A CA 2086101 A CA2086101 A CA 2086101A CA 2086101 A1 CA2086101 A1 CA 2086101A1
Authority
CA
Canada
Prior art keywords
milk
allergens
immune suppressive
intact
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002086101A
Other languages
English (en)
Other versions
CA2086101C (fr
Inventor
Lee R. Beck
Ralph J. Stolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Milk Biologics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2086101A1 publication Critical patent/CA2086101A1/fr
Application granted granted Critical
Publication of CA2086101C publication Critical patent/CA2086101C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002086101A 1990-07-05 1991-04-26 Produit immunosuppressif Expired - Fee Related CA2086101C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54841990A 1990-07-05 1990-07-05
US548,419 1990-07-05
PCT/US1991/002923 WO1992000756A1 (fr) 1990-07-05 1991-04-26 Produit immunosuppresseur

Publications (2)

Publication Number Publication Date
CA2086101A1 true CA2086101A1 (fr) 1992-01-06
CA2086101C CA2086101C (fr) 2002-11-19

Family

ID=24188777

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002086101A Expired - Fee Related CA2086101C (fr) 1990-07-05 1991-04-26 Produit immunosuppressif

Country Status (6)

Country Link
EP (1) EP0646017A1 (fr)
JP (1) JP3054194B2 (fr)
AU (1) AU648800B2 (fr)
CA (1) CA2086101C (fr)
NZ (2) NZ505179A (fr)
WO (1) WO1992000756A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
US7060687B2 (en) 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
US20020197268A1 (en) * 2001-06-08 2002-12-26 Hsu Ching-Hsaing Allergen-containing milk for allergy treatment
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20100129377A1 (en) * 2007-04-16 2010-05-27 Friesland Brands B.V. Milk derived antigen-specific antibodies, methods of preparation and uses thereof
NL1033696C2 (nl) * 2007-04-16 2008-10-20 Friesland Brands Bv Aan melk ontleende antigeen-specifieke antilichamen, werkwijzen voor het bereiden en gebruik ervan.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
USRE33403E (en) * 1982-06-03 1990-10-23 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
AU590711B2 (en) * 1982-10-13 1989-11-16 Biowhittaker, Inc. Stable allergenic extracts and methods

Also Published As

Publication number Publication date
JPH05508397A (ja) 1993-11-25
AU648800B2 (en) 1994-05-05
CA2086101C (fr) 2002-11-19
AU7891691A (en) 1992-02-04
EP0646017A4 (fr) 1993-07-12
EP0646017A1 (fr) 1995-04-05
NZ505179A (en) 2002-06-28
WO1992000756A1 (fr) 1992-01-23
JP3054194B2 (ja) 2000-06-19
NZ238117A (en) 1996-01-26

Similar Documents

Publication Publication Date Title
Berczi Pituitary function and immunity
CA2080462A1 (fr) Utilisation therapeutique de composes liant l'actine
ATE59402T1 (de) Verfahren zur abtrennung von cholesterin aus fettsubstanzen tierischen ursprungs und cholesterinarme fettsubstanzen.
EP0804734A4 (fr) Colonne sterile et apyrogene couplee a une proteine en vue de la fixation et de l'extraction de substances donnees du sang
WO1998026747A3 (fr) Procedes et compositions de traitement de maladies a base de superantigenes
WO1990003123A3 (fr) Micro-particules de proteine hydrophobe et leur preparation
EP0909814A3 (fr) Utilisation de protéine kinases pour le diagnostic et le traitement de la Maladie d'Alzheimer
DE3587266T2 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
IE892974L (en) Hydrophobic protein microparticles and preparation thereof
EP0313378A3 (fr) Méthodes et compositions pour l'elimination temporaire d'anticorps immuns humoraux
PT76502B (en) Process for the preparation of n-glycosylated carboxamide derivatives with s stimulating effect of the body's inherent defences and their application for the preparation of pharmaceutical compositions having a stimulating effect of body's inherent defences
AU3125289A (en) Monoclonal antibodies directed against human tumor necrosis factor - receptor
AU7827587A (en) Methods and agents for removing advanced glycosylation endproducts
DE68906858T2 (de) Verfahren zur Herstellung von einem proteinreichen Produkt, faserigem Produkt und/oder pflanzlichem Öl aus Korn von gebrauchter Bierhefe.
DE3466542D1 (en) Fraction containing immunoglobulin-g
GB2128195B (en) Protein derivative containing grafted ultraviolet-absorbing radicals the process for its preparation and compositions in which it is present
SE8602877L (sv) Extraktionsforfarande for mjolkproteiner, produkter, anvendning av forfarandet och farmaceutiska kompositioner
AU7752487A (en) Immunomodulating compositions and their use
DE69709691T2 (de) Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium
CA2086101A1 (fr) Produit immunosuppressif
DE59008883D1 (de) Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oder IgA-haltige Immunglobulinpräparate.
IE871967L (en) Binding-factor-related polypeptides
DE69101138T2 (de) Verfahren zur Herstellung von einem Milchprotein und/oder pflanzliches Protein und Verdickungsmittel enthaltenden Brotaufstrich und Vorrichtung zum Gebrauch dieses Verfahrens.
EP0493446A4 (en) Treatment of autoimmune disease
CH659586A5 (de) Arzneimittel aus dem thymus und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed